Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 745
interventional 548
Observational 177
Registry 20

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 224
Biological 75
Other 53
Drug|placebo 43
Biological|placebo 38
Behavioral 19
Procedure 17
Device 13
Diagnostic Test 11
Dietary Supplement 9
Dietary Supplement|Drug 8
Dietary Supplement|placebo 8
Behavioral|Other 4
Drug|Other 4
Biological|Drug 3
Behavioral|Drug 2
Biological|Other 2
Device|Other 2
Dietary Supplement|Other 2
Drug|Procedure|Radiation 2
Radiation 2
Behavioral|Biological 1
Behavioral|Combination Product 1
Behavioral|Device|Other 1
Behavioral|Drug|Other 1
Biological|Drug|Other 1
Drug|Procedure 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
South Africa 94
United States 63
United Kingdom 32
NA 27
China 20
India 17
Korea, Republic of 15
Uganda 11
France 10
Brazil 9
Indonesia 9
Tanzania 9
Thailand 9
Malawi 8
Netherlands 8
Spain 8
United States|Canada 8
Pakistan 7
Switzerland 7
Ethiopia 5
Kenya 5
Zambia 5
Belgium 4
Canada 4
Gambia 4
Russian Federation 4
Singapore 4
Taiwan 4
Vietnam 4
Haiti 3
Lesotho 3
South Africa|Tanzania 3
Bangladesh 2
Botswana 2
Denmark 2
Georgia 2
Germany 2
Ghana 2
Guinea-Bissau 2
Italy 2
Japan 2
Mexico 2
Mongolia 2
Mongolia|Ukraine 2
Nigeria 2
Peru|South Africa 2
Philippines 2
Philippines|South Africa 2
Senegal 2
Sweden 2
Ukraine 2
United States|Brazil|Canada|South Africa|Spain|Uganda 2
United States|Brazil|Canada|Spain 2
Armenia 1
Australia 1
Australia|Benin|Brazil|Canada|Ghana|Guinea|Indonesia 1
Australia|Benin|Brazil|Canada|Ghana|Guinea|Indonesia|Korea, Republic of|Saudi Arabia 1
Belarus|South Africa|Uzbekistan 1
Benin|Canada|Ghana|Indonesia|Vietnam 1
Botswana|Brazil|Haiti|India|Kenya|Peru|Philippines|South Africa|Tanzania|Thailand|Uganda|Zimbabwe 1
Botswana|Guinea|Mexico|Nepal|Pakistan|Peru|Uganda 1
Botswana|Haiti|India|South Africa|Tanzania|Thailand|Uganda|Zimbabwe 1
Botswana|India|South Africa|Tanzania 1
Botswana|Kenya|South Africa|Zimbabwe 1
Brazil|Côte D’Ivoire|France|Mozambique|Vietnam 1
Brazil|France 1
Brazil|Georgia|Malaysia|Philippines|Russian Federation|South Africa|Tanzania|Uganda 1
Brazil|Haiti|India|Kenya|Malawi|Peru|South Africa|Uganda|Zambia|Zimbabwe 1
Brazil|India|Latvia|Peru|Philippines|Russian Federation|South Africa|Thailand 1
Brazil|Philippines|Uganda 1
Burkina Faso|Cambodia|Cameroon|Vietnam 1
Côte D’Ivoire 1
Côte D’Ivoire|Mozambique|Uganda|Zambia 1
Cambodia 1
Cambodia|Cameroon|Côte D’Ivoire|Mozambique|Sierra Leone|Uganda 1
Cambodia|Cameroon|Côte D’Ivoire|Mozambique|Uganda|Zambia 1
Cambodia|Congo, The Democratic Republic of the|Nepal|Sudan 1
Cameroon|Kenya 1
Cameroon|Uganda 1
China|Estonia|Kenya|Korea, Republic of|Latvia|Peru|Philippines|Russian Federation|South Africa|Thailand|Turkey|Ukraine 1
China|Estonia|Korea, Republic of|Latvia|Peru|Philippines 1
China|India|Kenya|Malaysia|Mexico|South Africa|Tanzania|Thailand|Zambia 1
China|South Africa 1
Colombia 1
Congo, The Democratic Republic of the 1
Estonia 1
Estonia|Latvia|Lithuania|Moldova, Republic of|Peru|Philippines|South Africa 1
Ethiopia|Georgia|India|Moldova, Republic of|Mongolia|South Africa|Uganda 1
Finland 1
Georgia|India|Kazakhstan|Lesotho|Pakistan|Peru|South Africa 1
Georgia|Kenya|Malaysia|Philippines|South Africa|Tanzania|Uganda|Zambia 1
Georgia|Moldova, Republic of|Russian Federation|South Africa 1
Georgia|South Africa 1
Haiti|India|South Africa 1
Haiti|Kenya|Malawi|Thailand|Zimbabwe 1
India|Malawi 1
India|South Africa|Uganda|Zimbabwe 1
Indonesia|Peru|Romania 1
Indonesia|Philippines|Singapore|Thailand 1
Indonesia|Vietnam 1
Iran, Islamic Republic of 1
Israel 1
Italy|Netherlands|South Africa|Zimbabwe 1
Kazakhstan 1
Kazakhstan|Kyrgyzstan 1
Kenya|Mozambique|South Africa 1
Kenya|South Africa|Zambia 1
Kenya|Uganda 1
Latvia|Lithuania 1
Malawi|South Africa 1
Malaysia 1
Mozambique 1
Mozambique|Philippines|Russian Federation|South Africa|Uganda 1
Norway 1
Peru|Vietnam 1
Philippines|Singapore|Uganda 1
Saudi Arabia 1
Senegal|South Africa 1
South Africa|Tanzania|Uganda 1
South Africa|Tanzania|Zambia|Zimbabwe 1
South Africa|Zambia|Zimbabwe 1
Sudan 1
Thailand|Argentina|Brazil|Mexico|Peru|Russian Federation|South Africa 1
Uganda|Zambia 1
United States|Botswana|Brazil|Haiti|India|Kenya|Malawi|Peru|South Africa|Thailand|Uganda|Zambia|Zimbabwe 1
United States|Botswana|Brazil|Haiti|Kenya|Malawi|Peru|South Africa|Thailand|Zimbabwe 1
United States|Brazil 1
United States|Brazil|China|Haiti|India|Kenya|Malawi|Peru|South Africa|Thailand|Uganda|Vietnam|Zimbabwe 1
United States|Canada|South Africa|Uganda 1
United States|Canada|Uganda 1
United States|China|Egypt|Estonia|Japan|Korea, Republic of|Latvia|Peru|Philippines 1
United States|China|South Africa|Spain 1
United States|Peru|United Kingdom 1
United States|Puerto Rico 1
United States|South Africa 1
United States|South Africa|Uganda 1

Sites per Study

Site_count Study_Count
1 340
2 58
3 30
4 21
5 10
6 9
7 10
8 6
9 6
10 6
11 2
12 6
13 5
14 4
15 1
16 2
17 2
18 2
20 2
21 1
23 9
24 1
25 2
26 6
27 1
28 1
29 1
33 1
45 1
47 1
76 1

Phase

Phase Study_Count
N/A 161
Phase 2 125
Phase 1 113
Phase 3 70
Phase 4 40
Phase 1/Phase 2 20
Phase 2/Phase 3 14
Early Phase 1 5

Number of Arms

Number_of_Arms Count_of_Studies
1 75
2 233
3 69
4 48
5 25
6 21
7 5
8 9
9 3
10 2
12 3
13 1
19 1
NA 53

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 6.00 6.00000 20.0 2.000 60.000 62 7.000
1st Qu. 15.0 100.00 21.00000 46.0 47.000 229.250 288 99.000
Median 24.0 345.50 36.00000 72.0 99.000 535.000 650 300.000
Mean 77.4 10275.62 46.65179 104.3 230.472 1115.071 1396 2204.975
3rd Qu. 39.0 1162.25 48.00000 120.0 200.000 1706.250 1235 884.250
Max. 299.0 650000.00 1000.00000 487.0 3575.000 3400.000 10000 34758.000

Trial Group Type

group_type Group_Count
Experimental 846
Active Comparator 282
Placebo Comparator 145
No Intervention 72
Other 61
NA 53
Sham Comparator 7

Intervention Model

intervention_model Study_Count
Parallel Assignment 375
Single Group Assignment 101
Crossover Assignment 25
Sequential Assignment 20
Factorial Assignment 17
NA 10

Primary Purpose

primary_purpose Study_Count
Treatment 265
Prevention 135
Diagnostic 67
Health Services Research 26
Other 21
NA 10
Basic Science 9
Supportive Care 9
Screening 6

Observational Studies

Studies by Country

Country Study_Count
NA 23
Korea, Republic of 18
United States 18
China 8
India 8
Taiwan 7
Switzerland 6
South Africa 5
United Kingdom 5
Brazil 4
Ethiopia 4
Germany 4
Hong Kong 4
France 3
Ghana 3
Indonesia 3
Uganda 3
Italy 2
Mali 2
Moldova, Republic of 2
Peru 2
Romania 2
Vietnam 2
Zambia 2
Armenia|Bangladesh|Belarus|Ethiopia|Georgia|Indonesia|Kazakhstan|Kenya|Kyrgyzstan|Lesotho|Myanmar|Pakistan|Peru|South Africa 1
Australia|Belarus|Brazil|Greece|Italy|Latvia|Mexico|Netherlands|Portugal|South Africa|Sweden|Tanzania|United Kingdom 1
Australia|Bulgaria|Denmark|Germany|Greece|Italy|Netherlands|Portugal|Romania|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Belarus 1
Belarus|Georgia|India|South Africa 1
Belgium|Benin|Cameroon|Congo, The Democratic Republic of the|Ethiopia|Guinea|Mali|Nigeria|Rwanda|Senegal 1
Botswana|Brazil|India|Malawi|Peru|South Africa|Zimbabwe 1
Cambodia 1
Cambodia|Côte D’Ivoire 1
Canada 1
Ethiopia|Gambia|Germany|Namibia|Netherlands|South Africa|Uganda|United Kingdom 1
Ethiopia|India 1
Georgia|Germany|India|Moldova, Republic of|South Africa 1
India|Malawi|Mozambique|South Africa|Tanzania 1
India|Moldova, Republic of|South Africa 1
Israel 1
Kenya 1
Latvia 1
Lebanon 1
Lesotho|Peru|South Africa 1
Malawi|South Africa 1
Mozambique 1
Nepal 1
Netherlands 1
Russian Federation 1
Senegal 1
Singapore 1
South Africa|Uganda 1
South Africa|Zambia 1
Tanzania 1
Thailand 1
United States|Canada|South Africa|Uganda 1
United States|China 1
United States|Colombia|Mexico 1
United States|India 1
United States|Mali 1
United States|Mexico 1

Sites per Study

Site_count Study_Count
1 129
2 20
3 6
4 3
5 4
6 3
9 1
10 4
13 3
14 1
16 1
20 1
21 1

Enrollment Metrics

Measure Observational
Min 5.000
1st Qu 92.000
Median 229.000
Mean 1950.101
3rd Qu 625.750
Max 200000.000

Observation Model

observational_model Study_Count
Cohort 89
NA 25
Case-Only 22
Case-Control 14
Case Control 14
Other 7
Case-Crossover 3
Ecologic or Community 3

Time Perspective

time_perspective Study_Count
Prospective 132
Cross-Sectional 18
NA 11
Retrospective 9
Other 6
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
Korea, Republic of 3
China 2
France 2
India 2
Italy 2
Spain 2
Cameroon|Congo, The Democratic Republic of the|Côte D’Ivoire|India|Kenya|Lesotho|Malawi|Tanzania|Uganda|Zimbabwe 1
Gabon 1
Gambia|Mozambique|South Africa|Tanzania 1
Georgia 1
NA 1
Netherlands 1
Sweden 1

Sites per Study

Site_count Study_Count
1 14
2 1
3 1
4 1
5 1
6 1
10 1

Enrollment Metrics

Measure Registries
Min 8.00
1st Qu 75.50
Median 378.50
Mean 2025.25
3rd Qu 800.00
Max 30000.00

Registry Model

observational_model Study_Count
Cohort 15
Case-Only 2
Other 2
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 18
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
2 Years 4
6 Months 3
1 Year 2
12 Months 2
2 Months 2
1 Week 1
10 Years 1
15 Months 1
18 Months 1
18 Years 1
30 Years 1
8 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03409315 Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients https://ClinicalTrials.gov/show/NCT03409315 Recruiting University Medical Center Groningen 2020-11-30
NCT03383211 Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers https://ClinicalTrials.gov/show/NCT03383211 Active, not recruiting George Washington University 2019-09-01
NCT03305991 Tuberculosis Infection in Women of Reproductive Age and Their Infants https://ClinicalTrials.gov/show/NCT03305991 Active, not recruiting Lund University 2021-01-01
NCT03303963 DIAgnostics for Multidrug Resistant Tuberculosis in Africa https://ClinicalTrials.gov/show/NCT03303963 Recruiting Laboratoire de Référence des Mycobactéries 2020-12-31
NCT03228095 Volatiles in Breath and Headspace Analysis - Diagnostic Markers https://ClinicalTrials.gov/show/NCT03228095 Enrolling by invitation University of Latvia 2019-12-20
NCT03211208 Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients https://ClinicalTrials.gov/show/NCT03211208 Recruiting University of Edinburgh 2020-04-30
NCT03137875 Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis https://ClinicalTrials.gov/show/NCT03137875 Completed Epicentre 2012-12-31
NCT03096379 MRI Differentiating Gut TB and Crohn’s https://ClinicalTrials.gov/show/NCT03096379 Completed The University of Hong Kong 2018-12-30
NCT03080012 Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs https://ClinicalTrials.gov/show/NCT03080012 Completed University Medical Center Groningen 2018-05-02
NCT03072576 Accuracy and Feasibility of Xpert Ultra https://ClinicalTrials.gov/show/NCT03072576 Completed Foundation for Innovative New Diagnostics, Switzerland 2017-03-31
NCT03000517 PK of Levofloxacin in MDR-TB Patients https://ClinicalTrials.gov/show/NCT03000517 Completed University Medical Center Groningen 2017-10-27
NCT02984579 Line Probe Assay Evaluation Study https://ClinicalTrials.gov/show/NCT02984579 Completed Foundation for Innovative New Diagnostics, Switzerland 2016-01-31
NCT02978131 Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis https://ClinicalTrials.gov/show/NCT02978131 Completed Lille Catholic University 2016-06-30
NCT02875574 Improving the Management of Drug Resistant Tuberculosis in the UK https://ClinicalTrials.gov/show/NCT02875574 Completed University College, London 2017-12-31
NCT02759848 The Role of Tuberculosis in Chronic Obstructive Lung Disease https://ClinicalTrials.gov/show/NCT02759848 Completed Istanbul Medeniyet University 2014-12-31
NCT02758236 Tuberculosis Research of INA-RESPOND On Drug Resistance https://ClinicalTrials.gov/show/NCT02758236 Active, not recruiting Ina-Respond 2021-12-31
NCT02736864 Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae https://ClinicalTrials.gov/show/NCT02736864 Completed Federal University of Uberlandia 2017-10-31
NCT02729532 Effect of Xpert MTB/RIF on Patient Outcomes https://ClinicalTrials.gov/show/NCT02729532 Completed University of North Carolina, Chapel Hill 2018-02-09
NCT02727582 Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment https://ClinicalTrials.gov/show/NCT02727582 Active, not recruiting University of Cape Town 2018-11-14
NCT02712671 Testing for Tuberculosis in the United Kingdom HIV Infected Population https://ClinicalTrials.gov/show/NCT02712671 Active, not recruiting University College, London 2016-02-29
NCT02701439 SMF to Improve Performance of Microscopy for the Diagnosis of PTB in a High HIV Prevalence Setting https://ClinicalTrials.gov/show/NCT02701439 Completed Epicentre 2014-06-30
NCT02687529 Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection https://ClinicalTrials.gov/show/NCT02687529 Completed QIAGEN Gaithersburg, Inc 2015-11-07
NCT02653404 IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection https://ClinicalTrials.gov/show/NCT02653404 Recruiting University of Siena 2019-04-30
NCT02597621 Biomarkers for Therapy Response in Drug-resistant Tuberculosis https://ClinicalTrials.gov/show/NCT02597621 Active, not recruiting Research Center Borstel 2020-12-31
NCT01547884 Effect of Filarial Infection on Immune Responses in Latent Tuberculosis https://ClinicalTrials.gov/show/NCT01547884 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04443283 The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET https://ClinicalTrials.gov/show/NCT04443283 Enrolling by invitation Peking University Third Hospital 2022-12-30
NCT01212003 Training Protocol on the Natural History of Tuberculosis https://ClinicalTrials.gov/show/NCT01212003 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02534727 Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance https://ClinicalTrials.gov/show/NCT02534727 Completed National Institutes of Health Clinical Center (CC) 2018-01-11
NCT02413931 Nosocomial Transmission of MDR-TB in Bucharest, Romania https://ClinicalTrials.gov/show/NCT02413931 Active, not recruiting Research Center Borstel 2020-12-31
NCT02383849 IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants https://ClinicalTrials.gov/show/NCT02383849 Completed International Maternal Pediatric Adolescent AIDS Clinical Trials Group 2020-02-14
NCT02382107 A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania https://ClinicalTrials.gov/show/NCT02382107 Completed Ludwig-Maximilians - University of Munich 2016-05-31
NCT02027480 Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study https://ClinicalTrials.gov/show/NCT02027480 Completed Columbia University 2015-10-31
NCT02274389 A Prospective Patient Registry of Patients Exposed to Bedaquiline https://ClinicalTrials.gov/show/NCT02274389 Completed Janssen Research & Development, LLC 2018-11-20
NCT02256839 Evaluation of the QuantiFERON-TB Test. https://ClinicalTrials.gov/show/NCT02256839 Completed QIAGEN Gaithersburg, Inc 2015-10-31
NCT02253537 Evaluation of the QuantiFERON-TB Test. https://ClinicalTrials.gov/show/NCT02253537 Completed QIAGEN Gaithersburg, Inc 2016-04-26
NCT02252198 Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests https://ClinicalTrials.gov/show/NCT02252198 Completed Johns Hopkins University 2015-01-31
NCT02251327 Feasibility and Accuracy of a Novel Xpert Cartridge https://ClinicalTrials.gov/show/NCT02251327 Completed Johns Hopkins University 2015-06-15
NCT02176772 Iron Absorption and Utilization During Tuberculosis and After Treatment https://ClinicalTrials.gov/show/NCT02176772 Completed Swiss Federal Institute of Technology 2017-01-31
NCT02170441 Global Consortium for Drug-resistant Tuberculosis Diagnostics https://ClinicalTrials.gov/show/NCT02170441 Completed University of California, San Diego 2014-06-30
NCT02169141 Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients https://ClinicalTrials.gov/show/NCT02169141 Completed University Medical Center Groningen 2013-02-28
NCT02156882 Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique https://ClinicalTrials.gov/show/NCT02156882 Completed Ludwig-Maximilians - University of Munich 2016-05-31
NCT02142894 Evaluation of the QuantiFERON-TB Test. https://ClinicalTrials.gov/show/NCT02142894 Completed QIAGEN Gaithersburg, Inc 2016-03-28
NCT02135289 The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID https://ClinicalTrials.gov/show/NCT02135289 Completed Chinese University of Hong Kong 2019-07-31
NCT01317654 Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone https://ClinicalTrials.gov/show/NCT01317654 Completed Oxford University Clinical Research Unit, Vietnam 2008-04-30
NCT01311999 Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis https://ClinicalTrials.gov/show/NCT01311999 Completed National Taiwan University Hospital 2013-11-30
NCT01301144 Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis https://ClinicalTrials.gov/show/NCT01301144 Completed National Institutes of Health Clinical Center (CC) NA
NCT02043067 Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV https://ClinicalTrials.gov/show/NCT02043067 Completed University of North Carolina, Chapel Hill 2012-09-30
NCT01866579 Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT01866579 Completed Yonsei University 2014-05-31
NCT01850043 The Epidemiology of TST Change in Korea https://ClinicalTrials.gov/show/NCT01850043 Completed Asan Medical Center 2012-05-31
NCT01748357 Siemens VOC TB Pilot Study https://ClinicalTrials.gov/show/NCT01748357 Completed Research Center Borstel 2013-12-31
NCT03350048 Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB https://ClinicalTrials.gov/show/NCT03350048 Enrolling by invitation University of Stellenbosch 2019-06-30
NCT01622140 Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis https://ClinicalTrials.gov/show/NCT01622140 Active, not recruiting Centers for Disease Control and Prevention 2021-04-30
NCT01616264 Reproducibility of Computed Tomography https://ClinicalTrials.gov/show/NCT01616264 Completed Universidade Federal do Rio de Janeiro 2009-10-31
NCT01611402 Gene Expression in HIV and Tuberculosis Co-infection https://ClinicalTrials.gov/show/NCT01611402 Completed National Institutes of Health Clinical Center (CC) NA
NCT01608685 Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients https://ClinicalTrials.gov/show/NCT01608685 Completed Ligue Pulmonaire Genevoise 2011-12-31
NCT01601275 Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection https://ClinicalTrials.gov/show/NCT01601275 Completed Singapore General Hospital 2018-05-31
NCT01587677 Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis https://ClinicalTrials.gov/show/NCT01587677 Completed Research Center Borstel 2012-11-30
NCT01587469 Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects https://ClinicalTrials.gov/show/NCT01587469 Completed Cepheid 2014-02-21
NCT01585532 Alere Mycobacterium Tuberculosis Urine Study https://ClinicalTrials.gov/show/NCT01585532 Completed Research Center Borstel 2013-08-31
NCT01560078 Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion https://ClinicalTrials.gov/show/NCT01560078 Completed All India Institute of Medical Sciences, New Delhi 2011-10-31
NCT01539005 Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT01539005 Completed Centre for the AIDS Programme of Research in South Africa 2014-04-23
NCT01492595 Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda https://ClinicalTrials.gov/show/NCT01492595 Completed Epicentre 2014-04-30
NCT01456845 Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity https://ClinicalTrials.gov/show/NCT01456845 Completed All India Institute of Medical Sciences, New Delhi 2012-06-30
NCT01434758 Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture https://ClinicalTrials.gov/show/NCT01434758 Completed Oxford University Clinical Research Unit, Vietnam 2014-12-31
NCT01433796 Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment https://ClinicalTrials.gov/show/NCT01433796 Completed Lund University 2013-05-31
NCT01422798 An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda https://ClinicalTrials.gov/show/NCT01422798 Completed Epicentre 2014-12-31
NCT01392365 Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01392365 Completed Asan Medical Center 2015-02-28
NCT01390987 Access to Care and Adherence Tuberculosis (TB) Survey https://ClinicalTrials.gov/show/NCT01390987 Completed Azienda Ospedaliera San Gerardo di Monza 2012-09-30
NCT01376843 Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers https://ClinicalTrials.gov/show/NCT01376843 Completed Yonsei University 2012-05-31
NCT01371916 Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF https://ClinicalTrials.gov/show/NCT01371916 Completed Xijing Hospital 2013-11-30
NCT01364324 Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients https://ClinicalTrials.gov/show/NCT01364324 Recruiting National Cancer Center, Korea 2020-06-30
NCT04434976 Delayed Diagnosis of Bacteriologically Positive Pulmonary Tuberculosis and Relative Optimized Suggestions in China https://ClinicalTrials.gov/show/NCT04434976 Completed Huashan Hospital 2019-11-02
NCT04342598 Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India https://ClinicalTrials.gov/show/NCT04342598 Recruiting Harvard School of Public Health 2020-09-30
NCT04208789 Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis https://ClinicalTrials.gov/show/NCT04208789 Recruiting Hasanuddin University 2020-09-30
NCT04148053 Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis https://ClinicalTrials.gov/show/NCT04148053 Recruiting Tongji University 2019-12-31
NCT04147676 Evaluation of Centralised TB Assay Solutions https://ClinicalTrials.gov/show/NCT04147676 Recruiting Foundation for Innovative New Diagnostics, Switzerland 2020-08-01
NCT04179344 Usability Study of IeHS in Indonesia https://ClinicalTrials.gov/show/NCT04179344 Completed Bekasi City Public Hospital 2019-10-31
NCT03819374 Improving HIV/Tuberculosis Outcomes in Irkutsk https://ClinicalTrials.gov/show/NCT03819374 Recruiting University of Virginia 2020-05-31
NCT04089423 FujiLAM Prospective Evaluation Trial https://ClinicalTrials.gov/show/NCT04089423 Recruiting Foundation for Innovative New Diagnostics, Switzerland 2021-02-28
NCT04052022 Paradoxical Tuberculosis Reactions in Patients Without HIV Infection https://ClinicalTrials.gov/show/NCT04052022 Recruiting National Institutes of Health Clinical Center (CC) 2025-04-30
NCT04015713 Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset https://ClinicalTrials.gov/show/NCT04015713 Recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2021-03-31
NCT03993093 Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre https://ClinicalTrials.gov/show/NCT03993093 Completed Singh, Ranjan Kumar, M.D. 2020-02-28
NCT01269268 Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis https://ClinicalTrials.gov/show/NCT01269268 Completed Yonsei University 2014-05-14
NCT03941210 Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients https://ClinicalTrials.gov/show/NCT03941210 Recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2020-03-01
NCT03929705 Assessing the Ability of the T-SPOT®.TB Test https://ClinicalTrials.gov/show/NCT03929705 Active, not recruiting Oxford Immunotec 2020-04-30
NCT03927664 Clinico-radiological Classification of Peritoneal Tuberculosis https://ClinicalTrials.gov/show/NCT03927664 Recruiting Postgraduate Institute of Medical Education and Research 2020-04-30
NCT03923231 Pharmacokinetics of Atazanavir in Special Populations https://ClinicalTrials.gov/show/NCT03923231 Recruiting University of Liverpool 2022-05-31
NCT03898635 Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis https://ClinicalTrials.gov/show/NCT03898635 Recruiting Huashan Hospital 2019-05-01
NCT03827811 Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis https://ClinicalTrials.gov/show/NCT03827811 Recruiting University of Cape Town 2021-08-31
NCT03808636 Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections https://ClinicalTrials.gov/show/NCT03808636 Recruiting St George’s, University of London 2019-03-31
NCT03800407 Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection https://ClinicalTrials.gov/show/NCT03800407 Recruiting University of Florida 2023-01-31
NCT03800394 Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents https://ClinicalTrials.gov/show/NCT03800394 Recruiting University of Florida 2022-08-31
NCT03800381 Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet https://ClinicalTrials.gov/show/NCT03800381 Recruiting University of Florida 2022-08-30
NCT03794284 Multiplex PCR -Microarray-based Assay in the Detection of Mycobacterium https://ClinicalTrials.gov/show/NCT03794284 Recruiting Chinese University of Hong Kong 2020-02-29
NCT03767946 Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal https://ClinicalTrials.gov/show/NCT03767946 Recruiting Biomedical Research Center EPLS 2019-12-20
NCT03739736 TB Reduction Through ART and TB Screening Project https://ClinicalTrials.gov/show/NCT03739736 Enrolling by invitation London School of Hygiene and Tropical Medicine 2021-04-30
NCT03736278 Characteristics of Tuberculosis Infection in Rheumatic Disease https://ClinicalTrials.gov/show/NCT03736278 Completed National Taiwan University Hospital 2018-11-30
NCT03734172 Rapid and Accurate Diagnosis of Paediatric (RaPaed) TB - An AIDA (Assessment of Innovative Diagnostics and Algorithms for Early and Sensitive Detection of Acute TB) Platform Study https://ClinicalTrials.gov/show/NCT03734172 Recruiting Ludwig-Maximilians - University of Munich 2021-12-31
NCT03728725 Xpert MTB/XDR Clinical Evaluation Trial https://ClinicalTrials.gov/show/NCT03728725 Recruiting Foundation for Innovative New Diagnostics, Switzerland 2020-07-31
NCT03712709 Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test https://ClinicalTrials.gov/show/NCT03712709 Recruiting Foundation for Innovative New Diagnostics, Switzerland 2019-09-30
NCT03667742 Diagnosing of Acute Tuberculosis https://ClinicalTrials.gov/show/NCT03667742 Recruiting University Hospital, Basel, Switzerland 2020-06-30
NCT03559582 Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100) https://ClinicalTrials.gov/show/NCT03559582 Enrolling by invitation University of Virginia 2019-09-30
NCT03537170 Dietary Assessment and Prevalence of Refeeding Syndrome in High-risk TB Patients in Chhattisgarh, India https://ClinicalTrials.gov/show/NCT03537170 Completed Washington University School of Medicine 2018-02-14
NCT03507816 A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace https://ClinicalTrials.gov/show/NCT03507816 Recruiting University Hospital, Strasbourg, France 2020-02-29
NCT03470233 Deltyba Registry in MDR-TB Patients https://ClinicalTrials.gov/show/NCT03470233 Active, not recruiting Korea Otsuka Pharmaceutical Co., Ltd. 2020-06-30
NCT03459768 Cohort Study on People Who Inject Drugs in Senegal https://ClinicalTrials.gov/show/NCT03459768 Active, not recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2020-02-29
NCT03458338 Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa https://ClinicalTrials.gov/show/NCT03458338 Completed University Hospital, Basel, Switzerland 2011-05-30
NCT03423550 Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis https://ClinicalTrials.gov/show/NCT03423550 Recruiting Asan Medical Center 2019-06-30
NCT01252992 Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis https://ClinicalTrials.gov/show/NCT01252992 Completed Assistance Publique - Hôpitaux de Paris 2018-02-21
NCT01252537 Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia https://ClinicalTrials.gov/show/NCT01252537 Completed Lund University 2012-03-31
NCT01201941 Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru https://ClinicalTrials.gov/show/NCT01201941 Completed Brigham and Women’s Hospital 2009-03-31
NCT01167647 The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study https://ClinicalTrials.gov/show/NCT01167647 Completed Meir Medical Center 2012-10-31
NCT01162265 Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection https://ClinicalTrials.gov/show/NCT01162265 Completed Public Health England 2015-06-30
NCT01137370 The Impact of Vitamin D on Tuberculosis Among Koreans https://ClinicalTrials.gov/show/NCT01137370 Completed Seoul National University Hospital 2011-03-31
NCT01121068 Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients https://ClinicalTrials.gov/show/NCT01121068 Completed Seoul National University Hospital 2011-05-31
NCT01099098 Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB https://ClinicalTrials.gov/show/NCT01099098 Completed Seoul National University Hospital 2011-01-31
NCT01071603 Tuberculosis in China https://ClinicalTrials.gov/show/NCT01071603 Completed National Institutes of Health Clinical Center (CC) NA
NCT01053598 Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting https://ClinicalTrials.gov/show/NCT01053598 Completed Epicentre 2012-09-30
NCT01038830 QuantiFERON Change During Anti-tuberculosis Medication https://ClinicalTrials.gov/show/NCT01038830 Completed Armed Forces Capital Hospital, Republic of Korea 2010-04-30
NCT01021124 Latent Tuberculosis Infection in Bone Marrow Transplant Recipients https://ClinicalTrials.gov/show/NCT01021124 Completed Asan Medical Center 2013-06-30
NCT01002170 Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament https://ClinicalTrials.gov/show/NCT01002170 Completed Taipei Medical University WanFang Hospital 2009-06-30
NCT00982969 The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis https://ClinicalTrials.gov/show/NCT00982969 Completed Armed Forces Capital Hospital, Republic of Korea 2009-10-31
NCT00981071 The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure https://ClinicalTrials.gov/show/NCT00981071 Completed Armed Forces Capital Hospital, Republic of Korea 2010-04-30
NCT00979290 Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs https://ClinicalTrials.gov/show/NCT00979290 Completed E-DA Hospital 2009-11-30
NCT00978510 Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital Environment https://ClinicalTrials.gov/show/NCT00978510 Completed Sociedade Cearense de Infectologia NA
NCT00962793 Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ Assay https://ClinicalTrials.gov/show/NCT00962793 Completed Yonsei University NA
NCT00962676 Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients https://ClinicalTrials.gov/show/NCT00962676 Completed Yonsei University 2010-12-31
NCT00947609 Improving Latent Tuberculosis (TB) Diagnosis in Thai Children https://ClinicalTrials.gov/show/NCT00947609 Completed South East Asia Research Collaboration with Hawaii 2011-12-31
NCT00929786 Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity https://ClinicalTrials.gov/show/NCT00929786 Completed All India Institute of Medical Sciences, New Delhi 2009-04-30
NCT00889759 The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation https://ClinicalTrials.gov/show/NCT00889759 Completed Armed Forces Capital Hospital, Republic of Korea 2009-01-31
NCT00865826 Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals https://ClinicalTrials.gov/show/NCT00865826 Completed AIDS Clinical Trials Group 2011-03-31
NCT00834353 Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis https://ClinicalTrials.gov/show/NCT00834353 Completed Maulana Azad Medical College 2008-03-31
NCT00810446 Safety And Efficacy Of Rifabutin In HIV Patients https://ClinicalTrials.gov/show/NCT00810446 Completed Pfizer 2018-03-31
NCT01379066 Tuberculosis Volatile Organic Compounds https://ClinicalTrials.gov/show/NCT01379066 Completed Landon Pediatric Foundation 2009-12-31
NCT00803322 Improving Community Based Tuberculosis Care in Ethiopia https://ClinicalTrials.gov/show/NCT00803322 Completed University of Bergen 2007-09-30
NCT00814827 Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma https://ClinicalTrials.gov/show/NCT00814827 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03271567 Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients https://ClinicalTrials.gov/show/NCT03271567 Completed Chinese University of Hong Kong 2019-07-31
NCT03259269 Expand New Drugs for TB [endTB] https://ClinicalTrials.gov/show/NCT03259269 Active, not recruiting Partners in Health 2020-09-30
NCT02619240 Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB https://ClinicalTrials.gov/show/NCT02619240 Completed Chinese University of Hong Kong 2017-04-30
NCT02097095 Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972) https://ClinicalTrials.gov/show/NCT02097095 Completed Aeras 2016-11-30
NCT00810407 Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients https://ClinicalTrials.gov/show/NCT00810407 Completed Pfizer 2016-07-31
NCT02175849 Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis https://ClinicalTrials.gov/show/NCT02175849 Completed Oxford University Clinical Research Unit, Vietnam 2015-09-30
NCT00772408 Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis https://ClinicalTrials.gov/show/NCT00772408 Completed Chang Gung Memorial Hospital 2009-11-30
NCT00763295 Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV? https://ClinicalTrials.gov/show/NCT00763295 Completed Northwell Health 2010-01-31
NCT00756808 Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes? https://ClinicalTrials.gov/show/NCT00756808 Completed Northwell Health 2010-07-31
NCT00707317 T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals https://ClinicalTrials.gov/show/NCT00707317 Completed Tuberculosis Network European Trialsgroup 2011-05-31
NCT00695734 Detection of Latent Tuberculosis in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT00695734 Completed University Hospital, Geneva 2008-01-31
NCT00682045 Latent Tuberculosis Infection in Renal Transplant Recipients https://ClinicalTrials.gov/show/NCT00682045 Completed Asan Medical Center 2010-05-31
NCT00645697 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization https://ClinicalTrials.gov/show/NCT00645697 Completed Rafic Hariri University Hospital 2008-03-31
NCT00595907 Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis https://ClinicalTrials.gov/show/NCT00595907 Completed University Hospital, Geneva 2006-07-31
NCT00567151 Co-Infection of NTM in Patients With Smear Positive Pulmonary TB https://ClinicalTrials.gov/show/NCT00567151 Completed Seoul National University Hospital 2008-12-31
NCT00557765 Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area https://ClinicalTrials.gov/show/NCT00557765 Completed University Hospital, Geneva NA
NCT00507754 Latent Tuberculosis Infection in Cancer Patients https://ClinicalTrials.gov/show/NCT00507754 Completed M.D. Anderson Cancer Center 2011-05-31
NCT00472316 Innovative Approaches to Tuberculosis Control https://ClinicalTrials.gov/show/NCT00472316 Completed Johns Hopkins University 2009-10-31
NCT00421798 Rapid Characterization of Paucibacillary TB Along Tex/Mex Border https://ClinicalTrials.gov/show/NCT00421798 Completed The University of Texas Health Science Center, Houston 2009-01-31
NCT00414882 A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding https://ClinicalTrials.gov/show/NCT00414882 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-06-28
NCT00341601 Multi-Drug Resistant Tuberculosis in Korea https://ClinicalTrials.gov/show/NCT00341601 Completed National Institutes of Health Clinical Center (CC) NA
NCT00346476 Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa https://ClinicalTrials.gov/show/NCT00346476 Completed CIPRA SA 2010-12-31
NCT00340990 Immune Responses to Mycobacterium Tuberculosis https://ClinicalTrials.gov/show/NCT00340990 Completed National Institutes of Health Clinical Center (CC) NA
NCT00266383 The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population https://ClinicalTrials.gov/show/NCT00266383 Completed National Health Research Institutes, Taiwan NA
NCT00257907 Immune Response to Mycobacterium Tuberculosis Infection https://ClinicalTrials.gov/show/NCT00257907 Completed National Institutes of Health Clinical Center (CC) NA
NCT00201253 Expression of Tuberculosis in the Lung https://ClinicalTrials.gov/show/NCT00201253 Completed Rutgers, The State University of New Jersey 2008-06-30
NCT00173433 Exogenous Reinfection of Tuberculosis in Taiwan https://ClinicalTrials.gov/show/NCT00173433 Completed National Taiwan University Hospital 2006-07-31
NCT00170638 Tuberculosis Immunity in Children https://ClinicalTrials.gov/show/NCT00170638 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00149448 Effectiveness of the TB Contact Priority Model https://ClinicalTrials.gov/show/NCT00149448 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-03-31
NCT00134342 Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations https://ClinicalTrials.gov/show/NCT00134342 Completed University Health Network, Toronto 2005-04-30
NCT00096681 Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa https://ClinicalTrials.gov/show/NCT00096681 Completed CIPRA SA 2005-08-31
NCT00054769 Diagnosing Tuberculosis in HIV Infected Children in Peru https://ClinicalTrials.gov/show/NCT00054769 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-02-28
NCT00023439 TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment https://ClinicalTrials.gov/show/NCT00023439 Completed Centers for Disease Control and Prevention NA
NCT00000785 A Registry of Tuberculosis Cases in the CPCRA https://ClinicalTrials.gov/show/NCT00000785 Completed National Institute of Allergy and Infectious Diseases (NIAID) 1994-06-30
NCT00005742 Behavioral Interventions for Control of Tuberculosis https://ClinicalTrials.gov/show/NCT00005742 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005741 Indigenous Outreach Among Injection Drug Users to Treat and Control TB https://ClinicalTrials.gov/show/NCT00005741 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005740 TB Contact Investigation: Behavioral Intervention https://ClinicalTrials.gov/show/NCT00005740 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005739 Behavioral Interventions for Control of TB https://ClinicalTrials.gov/show/NCT00005739 Completed Columbia University 2004-12-31
NCT00005738 Promoting Adherence to TB Regimens in Latino Adolescents https://ClinicalTrials.gov/show/NCT00005738 Completed San Diego State University NA
NCT00005737 Tuberculosis Prophylaxis in the Homeless–A Controlled Trial https://ClinicalTrials.gov/show/NCT00005737 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005379 Tuberculosis in a Multiethnic Inner City Population https://ClinicalTrials.gov/show/NCT00005379 Completed NYU Langone Health 1999-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03251196 TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB https://ClinicalTrials.gov/show/NCT03251196 Recruiting The Aurum Institute NPC 2022-06-30
NCT03057756 Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance https://ClinicalTrials.gov/show/NCT03057756 Active, not recruiting Centre de Recherche Médicale de Lambaréné 2021-04-04
NCT02715271 Study of TB Lesions Obtained in Therapeutical Surgery https://ClinicalTrials.gov/show/NCT02715271 Active, not recruiting Fundació Institut Germans Trias i Pujol 2020-07-31
NCT02681445 Non-invasive TB Triage and Patient Mapping Platform Using Breath Via Low-Cost Titanium Dioxide Nanotube Sensor https://ClinicalTrials.gov/show/NCT02681445 Completed University of Utah 2017-11-30
NCT02042261 The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study https://ClinicalTrials.gov/show/NCT02042261 Completed Linkoeping University 2015-11-30
NCT02527486 Seoul National University Airway Registry https://ClinicalTrials.gov/show/NCT02527486 Recruiting Seoul National University Hospital 2021-12-31
NCT02454569 Vicente Ferrer HIV Cohort Study https://ClinicalTrials.gov/show/NCT02454569 Recruiting Rural Development Trust Hospital 2039-09-30
NCT02331056 Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy? https://ClinicalTrials.gov/show/NCT02331056 Completed Samsung Medical Center 2015-06-30
NCT02115854 Labial Biopsy in Patients With Tuberculosis Disease https://ClinicalTrials.gov/show/NCT02115854 Completed Hopital Lariboisière 2014-04-30
NCT02045394 Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study https://ClinicalTrials.gov/show/NCT02045394 Completed University of Milan 2015-10-31
NCT04236349 Tuberculosis Cohort in the North of Paris https://ClinicalTrials.gov/show/NCT04236349 Recruiting Assistance Publique - Hôpitaux de Paris 2020-01-31
NCT04079400 Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemoptysis https://ClinicalTrials.gov/show/NCT04079400 Completed Gachon University Gil Medical Center 2018-10-30
NCT04074369 Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects https://ClinicalTrials.gov/show/NCT04074369 Recruiting Huashan Hospital 2019-10-30
NCT04055584 PCR Techniques of Dried Sputum Using a Spotcard https://ClinicalTrials.gov/show/NCT04055584 Recruiting University Medical Center Groningen 2020-11-30
NCT03948698 TB Innovation Project: A Pre- and Post- Implementation Assessment (TIPPI) https://ClinicalTrials.gov/show/NCT03948698 Active, not recruiting Elizabeth Glaser Pediatric AIDS Foundation 2021-09-30
NCT03691883 Design of an Integrative Algorithm for Staging Tuberculosis https://ClinicalTrials.gov/show/NCT03691883 Recruiting Fundació Institut Germans Trias i Pujol 2020-09-30
NCT03625739 Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis https://ClinicalTrials.gov/show/NCT03625739 Recruiting Beijing Children’s Hospital 2026-10-01
NCT03416309 Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response https://ClinicalTrials.gov/show/NCT03416309 Recruiting University of Turin, Italy 2021-02-28
NCT03822156 Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort https://ClinicalTrials.gov/show/NCT03822156 Completed University of Ulsan 2018-06-30
NCT04002869 Innovation in Tuberculosis https://ClinicalTrials.gov/show/NCT04002869 Recruiting Fundació Institut Germans Trias i Pujol 2020-06-30